bibliographicCitation |
Sun S, Zhang Z, Raina V, Pokrovskaia N, Hou D, Namdari R, Khakh K, Ratkay LG, McLaren DG, Mork M, Fu J, Ferreira S, Hubbard B, Winther MD, Dales N. Discovery of thiazolylpyridinone SCD1 inhibitors with preferential liver distribution and reduced mechanism-based adverse effects. Bioorganic & Medicinal Chemistry Letters. 2014 Jan;24(2):526–31. doi: 10.1016/j.bmcl.2013.12.035. |